I believe that if more women were equally in charge, this world would be a safer planet. But a recent medical announcement about female sexuality makes me wonder if women should be careful what equalities they wish for—like the pink pill, Addyi (flibanserin) that’s just been approved in the U.S.
We know that the blue pill has had a major impact on male sexuality. It’s been 17 years since Viagra was approved for the treatment of erectile dysfunction (ED). Since then 25 drugs have been approved to treat male sexual problems and zero for women.
